Clark Capital Management Group, Inc. Abb Vie Inc. Transaction History
Clark Capital Management Group, Inc.
- $14.3 Billion
- Q3 2024
A detailed history of Clark Capital Management Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 3,729 shares of ABBV stock, worth $635,235. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,729
Previous 8,170
54.36%
Holding current value
$635,235
Previous $1.4 Million
47.47%
% of portfolio
0.01%
Previous 0.01%
Shares
32 transactions
Others Institutions Holding ABBV
# of Institutions
3,817Shares Held
1.25BCall Options Held
13MPut Options Held
10M-
Vanguard Group Inc Valley Forge, PA172MShares$29.2 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.2 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.5 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.88 Billion0.84% of portfolio
-
Morgan Stanley New York, NY37.2MShares$6.34 Billion0.5% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $301B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...